| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T F Linsenmayer, F Long, M Nurminskaya, Q Chen, T M Schmi. Type X collagen and other up-regulated components of the avian hypertrophic cartilage program. Progress in nucleic acid research and molecular biology. vol 60. 1998-06-15. PMID:9594572. |
we provide evidence that the molecule has unique diffusion and regulatory properties that combine to alter the hypertrophic cartilage matrix. |
1998-06-15 |
2023-08-12 |
Not clear |
| B O Oyajobi, A Frazer, A P Hollander, R M Graveley, C Xu, A Houghton, P V Hatton, R G Russell, B M Stringe. Expression of type X collagen and matrix calcification in three-dimensional cultures of immortalized temperature-sensitive chondrocytes derived from adult human articular cartilage. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. vol 13. issue 3. 1998-06-10. PMID:9525344. |
in addition, in the presence of ascorbate but in the absence of a phosphate donor or inorganic phosphate supplement, the cells also begin to express a hypertrophic phenotype characterized by type x collagen synthesis and extensive mineralization of the extracellular matrix in late stage cultures. |
1998-06-10 |
2023-08-12 |
human |
| K Ohshiro, P Pur. Pathogenesis of infantile hypertrophic pyloric stenosis: recent progress. Pediatric surgery international. vol 13. issue 4. 1998-06-10. PMID:9553181. |
reviews of the recent progress in the pathogenesis of ihps show: (1) there is increasing evidence to suggest that smooth-muscle cells in ihps are not properly innervated; (2) because non-adrenergic, non-cholinergic nerves are mediators of smooth-muscle relaxation, it is likely that the absence of these nerves in pyloric muscle is the cause of excessively contracted hypertrophic circular pyloric muscle; (3) there are abnormal amounts of extracellular matrix proteins in hypertrophic pyloric muscle. |
1998-06-10 |
2023-08-12 |
Not clear |
| P Vanky, U Brockstedt, A Hjerpe, B Wikströ. Kinetic studies on epiphyseal growth cartilage in the normal mouse. Bone. vol 22. issue 4. 1998-06-03. PMID:9556132. |
the largest increases in matrix volume occurred in the hypertrophic zone. |
1998-06-03 |
2023-08-12 |
mouse |
| S G Adler, G S Lee, A H Cohen, C C Nas. Corticomedullary procollagen alpha1(IV) mRNA levels and localization after subtotal nephrectomy. Mineral and electrolyte metabolism. vol 24. issue 4. 1998-05-28. PMID:9554563. |
these studies demonstrated that an increase in mrna for classical type iv collagen is not required for the development of hypertrophy, and that the increment is a better marker for matrix expansion than it is for hypertrophy. |
1998-05-28 |
2023-08-12 |
rat |
| B B Hoffman, K Sharma, F N Ziyade. Potential role of TGF-beta in diabetic nephropathy. Mineral and electrolyte metabolism. vol 24. issue 2-3. 1998-05-01. PMID:9525704. |
transforming growth factor-beta (tgf-beta) is one such factor because it promotes renal cell hypertrophy and regulates the production of extracellular matrix molecules. |
1998-05-01 |
2023-08-12 |
mouse |
| B B Hoffman, K Sharma, F N Ziyade. Potential role of TGF-beta in diabetic nephropathy. Mineral and electrolyte metabolism. vol 24. issue 2-3. 1998-05-01. PMID:9525704. |
neutralizing anti-tgf-beta antibodies or antisense tgf-beta1 oligodeoxynucleotides prevents the hypertrophic effects of high glucose and the stimulation of matrix synthesis in renal cells. |
1998-05-01 |
2023-08-12 |
mouse |
| B B Hoffman, K Sharma, F N Ziyade. Potential role of TGF-beta in diabetic nephropathy. Mineral and electrolyte metabolism. vol 24. issue 2-3. 1998-05-01. PMID:9525704. |
we also demonstrated that short-term treatment of streptozotocin-diabetic mice with neutralizing monoclonal antibody directed against tgf-beta significantly reduces kidney weight and glomerular hypertrophy, and attenuates the increase in extracellular matrix mrna levels. |
1998-05-01 |
2023-08-12 |
mouse |
| C A Tozzi, S Thakker-Varia, S Y Yu, R F Bannett, B W Peng, G J Poiani, F J Wilson, D J Rile. Mast cell collagenase correlates with regression of pulmonary vascular remodeling in the rat. American journal of respiratory cell and molecular biology. vol 18. issue 4. 1998-04-30. PMID:9533937. |
pulmonary vascular remodeling, produced by cell hypertrophy and extracellular matrix protein synthesis in response to hemodynamic stress, regresses after reduction of blood pressure, possibly by proteolysis of structural proteins. |
1998-04-30 |
2023-08-12 |
rat |
| F Pietruck, S Spleiter, A Daul, T Philipp, M Derwahl, H Schatz, W Siffer. Enhanced G protein activation in IDDM patients with diabetic nephropathy. Diabetologia. vol 41. issue 1. 1998-04-27. PMID:9498636. |
a consequence of the altered metabolic milieu in diabetes is the increased release of vasoactive and proliferative agonists which promote glomerular hyperfiltration, hypertrophy, enhanced matrix deposition, and, finally, glomerulosclerosis. |
1998-04-27 |
2023-08-12 |
human |
| F R Bühle. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. vol 15. issue 5. 1998-03-26. PMID:9481610. |
these and other factors reduce smooth muscle cell proliferation, hypertrophy and matrix deposition. |
1998-03-26 |
2023-08-12 |
Not clear |
| B Corman, M Duriez, P Poitevin, D Heudes, P Bruneval, A Tedgui, B I Lev. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proceedings of the National Academy of Sciences of the United States of America. vol 95. issue 3. 1998-03-11. PMID:9448326. |
the prevention of arterial stiffening and cardiac hypertrophy in the absence of changes in collagen and elastin content suggests that the effect of aminoguanidine is related to a decrease in the age-induced cross-linking of the extracellular matrix. |
1998-03-11 |
2023-08-12 |
rat |
| N Boos, A G Nerlich, I Wiest, K von der Mark, M Aeb. Immunolocalization of type X collagen in human lumbar intervertebral discs during ageing and degeneration. Histochemistry and cell biology. vol 108. issue 6. 1998-02-25. PMID:9450629. |
immunohistochemically, a positive specific type x staining was observed in the hypertrophic zone of the growth plate and only in the interstitial matrix of juvenile (<2 years) nucleus pulposus. |
1998-02-25 |
2023-08-12 |
human |
| B Johnstone, T M Hering, A I Caplan, V M Goldberg, J U Yo. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental cell research. vol 238. issue 1. 1998-02-23. PMID:9457080. |
by 14 days of culture, there was also evidence for type x collagen present in the matrix and the cells morphologically resembled hypertrophic chondrocytes. |
1998-02-23 |
2023-08-12 |
rabbit |
| L Rai. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension (Dallas, Tex. : 1979). vol 31. issue 1 Pt 2. 1998-02-20. PMID:9453301. |
specifically, in the presence of hypertension, nitric oxide may work in the kidney by inhibiting both mesangial cell hypertrophy and hyperplasia as well as synthesis of extracellular matrix and in the heart and systemic vessels by modulating smooth muscle cell hypertrophy and hyperplasia. |
1998-02-20 |
2023-08-12 |
rat |
| A C Pessina, A Sacchetto, G P Ross. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension. Advances in experimental medicine and biology. vol 432. 1998-02-17. PMID:9433512. |
compelling evidence suggests that both the renin-angiotensin system (ras) and the aldosterone excess play an important role in the pathogenesis of lvh, since experimentally angiotensin ii has been found to cause myocardial cells hypertrophy and/or hyperplasia and excess aldosterone has been related to extracellular matrix and collagen deposition and therefore to myocardial fibrosis. |
1998-02-17 |
2023-08-12 |
Not clear |
| N Kergosien, J Sautier, N Fores. Gene and protein expression during differentiation and matrix mineralization in a chondrocyte cell culture system. Calcified tissue international. vol 62. issue 2. 1998-02-11. PMID:9437044. |
however, our culture conditions promoted extracellular matrix mineralization and cell differentiation towards the hypertrophic phenotype. |
1998-02-11 |
2023-08-12 |
rat |
| M S Hirsch, L E Lunsford, V Trinkaus-Randall, K K Svobod. Chondrocyte survival and differentiation in situ are integrin mediated. Developmental dynamics : an official publication of the American Association of Anatomists. vol 210. issue 3. 1998-02-10. PMID:9389451. |
cephalic chondrocytes become hypertrophic and secrete type x collagen into the extracellular matrix prior to bone deposition. |
1998-02-10 |
2023-08-12 |
chicken |
| E Bonucci, G Silvestrini, P Mocett. MC22-33F monoclonal antibody shows unmasked polar head groups of choline-containing phospholipids in cartilage and bone. European journal of histochemistry : EJH. vol 41. issue 3. 1998-01-26. PMID:9359029. |
the mc22-33f mab immunoreaction was found in the cytoplasm of maturing and hypertrophic and, to a lesser extent, proliferating and degenerating chondrocytes; it was strongly positive in matrix vesicles, at the periphery of calcification nodules, and at the periphery of calcified matrix. |
1998-01-26 |
2023-08-12 |
Not clear |
| L J Zhou, M Inoue, I Ono, F Kanek. The mode of action of prostaglandin (PG) I1 analog, SM-10906, on fibroblasts of hypertrophic scars is similar to PGE1 in its potential role of preventing scar formation. Experimental dermatology. vol 6. issue 6. 1998-01-22. PMID:9412820. |
the effects of prostaglandin (pg) i1 analog, sm-10906 (sm-6) and pge1 on extracellular matrix formation and the release of cytokines by cultured normal human dermal fibroblasts (ndf) and hypertrophic scar fibroblasts (hsf) were compared in order to evaluate the clinical efficacy of pgs in preventing scar formation. |
1998-01-22 |
2023-08-12 |
human |